Proteomic and genomic signatures of repeat instability in cancer and adjacent normal tissues.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
20 08 2019
Historique:
pubmed: 8 8 2019
medline: 24 3 2020
entrez: 8 8 2019
Statut: ppublish

Résumé

Repetitive sequences are hotspots of evolution at multiple levels. However, due to difficulties involved in their assembly and analysis, the role of repeats in tumor evolution is poorly understood. We developed a rigorous motif-based methodology to quantify variations in the repeat content, beyond microsatellites, in proteomes and genomes directly from proteomic and genomic raw data. This method was applied to a wide range of tumors and normal tissues. We identify high similarity between repeat instability patterns in tumors and their patient-matched adjacent normal tissues. Nonetheless, tumor-specific signatures both in protein expression and in the genome strongly correlate with cancer progression and robustly predict the tumorigenic state. In a patient, the hierarchy of genomic repeat instability signatures accurately reconstructs tumor evolution, with primary tumors differentiated from metastases. We observe an inverse relationship between repeat instability and point mutation load within and across patients independent of other somatic aberrations. Thus, repeat instability is a distinct, transient, and compensatory adaptive mechanism in tumor evolution and a potential signal for early detection.

Identifiants

pubmed: 31387980
pii: 1908790116
doi: 10.1073/pnas.1908790116
pmc: PMC6708321
doi:

Substances chimiques

Neoplasm Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

16987-16996

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

J Mol Biol. 1999 Oct 15;293(1):151-60
pubmed: 10512723
Science. 2000 Nov 10;290(5494):1151-5
pubmed: 11073452
Nature. 1975 May 15;255(5505):197-200
pubmed: 1143315
Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):333-8
pubmed: 11782551
Genome Biol. 2002;3(2):RESEARCH0008
pubmed: 11864370
Cancer Res. 2002 May 1;62(9):2447-54
pubmed: 11980631
Trends Immunol. 2003 Oct;24(10):528-33
pubmed: 14552836
Science. 2003 Nov 21;302(5649):1401-4
pubmed: 14631042
Protein Sci. 2004 Jun;13(6):1435-48
pubmed: 15152081
Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18058-63
pubmed: 15596718
J Clin Oncol. 2005 Jan 20;23(3):609-18
pubmed: 15659508
Nat Genet. 2005 Sep;37(9):986-90
pubmed: 16086015
Nat Rev Genet. 2005 Oct;6(10):729-42
pubmed: 16205713
Nat Rev Genet. 2005 Oct;6(10):743-55
pubmed: 16205714
Trends Genet. 2006 May;22(5):253-9
pubmed: 16567018
Nat Rev Cancer. 2008 Jan;8(1):56-61
pubmed: 18059462
Nature. 2009 Apr 9;458(7239):719-24
pubmed: 19360079
Science. 2009 May 29;324(5931):1213-6
pubmed: 19478187
Mol Cell. 2009 Aug 14;35(3):260-4
pubmed: 19683491
Nat Rev Genet. 2010 Feb;11(2):97-108
pubmed: 20051986
Nat Rev Mol Cell Biol. 2010 Mar;11(3):165-70
pubmed: 20177394
Nat Rev Genet. 2010 Apr;11(4):247-58
pubmed: 20177426
Annu Rev Genet. 2010;44:445-77
pubmed: 20809801
Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18545-50
pubmed: 20876136
Cell. 2011 Jan 7;144(1):27-40
pubmed: 21215367
Cancer Res. 2011 May 15;71(10):3447-52
pubmed: 21270108
Annu Rev Biochem. 2011;80:613-43
pubmed: 21495847
Nat Rev Genet. 2011 Nov 29;13(1):36-46
pubmed: 22124482
Nature. 2012 Jan 18;481(7381):306-13
pubmed: 22258609
Nat Rev Genet. 2012 Jan 24;13(3):189-203
pubmed: 22269907
J Clin Invest. 2012 Apr;122(4):1138-43
pubmed: 22466654
Nat Genet. 2012 May 20;44(6):685-9
pubmed: 22610119
Nature. 2012 Oct 4;490(7418):61-70
pubmed: 23000897
Nat Rev Genet. 2012 Nov;13(11):795-806
pubmed: 23044827
Proc Natl Acad Sci U S A. 2012 Dec 18;109(51):21010-5
pubmed: 23197825
Nat Rev Genet. 2013 Mar;14(3):157-67
pubmed: 23358380
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2910-5
pubmed: 23388632
Cell. 2013 Apr 25;153(3):666-77
pubmed: 23622249
Nature. 2013 Jul 11;499(7457):214-218
pubmed: 23770567
Nature. 2013 Sep 19;501(7467):338-45
pubmed: 24048066
PLoS Comput Biol. 2013;9(11):e1003346
pubmed: 24278003
PLoS Comput Biol. 2013;9(12):e1003345
pubmed: 24348224
Nature. 2014 Mar 20;507(7492):315-22
pubmed: 24476821
Mol Biol Evol. 2014 May;31(5):1132-48
pubmed: 24497029
Nature. 2014 Jul 31;511(7511):543-50
pubmed: 25079552
Genome Biol. 2014 Aug 26;15(8):439
pubmed: 25160065
Syst Biol. 2015 Jan;64(1):e1-25
pubmed: 25293804
Science. 2015 Jan 2;347(6217):78-81
pubmed: 25554788
Nat Rev Cancer. 2014 Dec;14(12):786-800
pubmed: 25568919
Nat Rev Clin Oncol. 2015 May;12(5):258-72
pubmed: 25601447
Nat Genet. 2015 Apr;47(4):367-372
pubmed: 25730763
Science. 2015 May 22;348(6237):880-6
pubmed: 25999502
Cell. 2015 Nov 5;163(4):1011-25
pubmed: 26544944
Nat Med. 2016 Jan;22(1):105-13
pubmed: 26618723
Eur Urol. 2016 May;69(5):942-52
pubmed: 26651926
Nat Med. 2016 Jan;22(1):97-104
pubmed: 26657142
Nat Genet. 2016 Mar;48(3):238-244
pubmed: 26780609
Nat Med. 2016 Mar;22(3):298-305
pubmed: 26855148
Sci Transl Med. 2016 Feb 24;8(327):327ra26
pubmed: 26912905
Immunity. 2016 Mar 15;44(3):525-526
pubmed: 26982362
Immunity. 2016 Mar 15;44(3):698-711
pubmed: 26982367
Cell Syst. 2016 Mar 23;2(3):172-84
pubmed: 27135363
Nat Genet. 2016 Jul;48(7):725-32
pubmed: 27240091
Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):E5528-37
pubmed: 27573852
Nat Med. 2016 Nov;22(11):1342-1350
pubmed: 27694933
Nat Genet. 2016 Dec;48(12):1490-1499
pubmed: 27749842
Nat Commun. 2016 Nov 18;7:13570
pubmed: 27857066
J Virol. 2017 Jan 31;91(4):
pubmed: 27928012
Science. 2017 Feb 17;355(6326):752-756
pubmed: 28209900
Nat Rev Cancer. 2017 Apr;17(4):209-222
pubmed: 28233802
Science. 2017 Mar 24;355(6331):1330-1334
pubmed: 28336671
Nat Struct Mol Biol. 2017 Sep;24(9):765-777
pubmed: 28805808
Cell. 2017 Nov 16;171(5):1042-1056.e10
pubmed: 29056344
Cell. 2017 Nov 16;171(5):1029-1041.e21
pubmed: 29056346
Nat Genet. 2017 Dec;49(12):1785-1788
pubmed: 29106416
Nature. 2017 Dec 7;552(7683):116-120
pubmed: 29186113
N Engl J Med. 2017 Dec 21;377(25):2500-2501
pubmed: 29262275
Nat Rev Cancer. 2018 Sep;18(9):576-585
pubmed: 29891961
Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):E11101-E11110
pubmed: 30404913
Mol Biol Evol. 1987 May;4(3):203-21
pubmed: 3328815
Cancer Res. 1974 Sep;34(9):2311-21
pubmed: 4136142
Nature. 1994 Sep 15;371(6494):215-20
pubmed: 8078581
Nature. 1994 Sep 22;371(6495):297-300
pubmed: 8090199
Nat Genet. 1994 Feb;6(2):152-6
pubmed: 8162069
Nature. 1993 Jun 10;363(6429):558-61
pubmed: 8505985
Mol Cell Biol. 1998 Apr;18(4):2045-54
pubmed: 9528777
Science. 1976 Oct 1;194(4260):23-8
pubmed: 959840
Nature. 1998 Dec 17;396(6712):643-9
pubmed: 9872311

Auteurs

Erez Persi (E)

School of Physics and Astronomy, Raymond & Beverly Sackler Faculty of Exact Sciences, Tel Aviv University, 69978 Tel Aviv, Israel; erezpersi@gmail.com koonin@ncbi.nlm.nih.gov f.demichelis@unitn.it horn@tau.ac.il.
Center for Bioinformatics and Computational Biology, Institute of Advanced Computer Studies, University of Maryland, College Park, MD 20742.
National Center for Biotechnology Information, National Library of Medicine, NIH, Bethesda, MD 20894.

Davide Prandi (D)

Department of Cellular, Computational and Integrative Biology, University of Trento, 38123 Trento, Italy.

Yuri I Wolf (YI)

National Center for Biotechnology Information, National Library of Medicine, NIH, Bethesda, MD 20894.

Yair Pozniak (Y)

Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, 69978 Tel Aviv, Israel.

Georgina D Barnabas (GD)

Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, 69978 Tel Aviv, Israel.

Keren Levanon (K)

Sheba Cancer Research Center, Chaim Sheba Medical Center, 52621 Ramat Gan, Israel.
Sackler Faculty of Medicine, Tel Aviv University, 69978 Tel Aviv, Israel.

Iris Barshack (I)

Department of Pathology, Chaim Sheba Medical Center, 52621 Ramat Gan, Israel.

Christopher Barbieri (C)

Department of Urology, Weill Cornell Medicine, New York, NY 10065.
Englander Institute for Precision Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY 10065.

Paola Gasperini (P)

Department of Cellular, Computational and Integrative Biology, University of Trento, 38123 Trento, Italy.

Himisha Beltran (H)

Englander Institute for Precision Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY 10065.
Division of Hematology and Medical Oncology, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10065.

Bishoy M Faltas (BM)

Englander Institute for Precision Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY 10065.
Division of Hematology and Medical Oncology, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10065.

Mark A Rubin (MA)

Department for BioMedical Research, University of Bern, Switzerland Center for Precision Medicine, Inselspital, Bern University Hospital, 3008 Bern, Switzerland.

Tamar Geiger (T)

Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, 69978 Tel Aviv, Israel.

Eugene V Koonin (EV)

National Center for Biotechnology Information, National Library of Medicine, NIH, Bethesda, MD 20894; erezpersi@gmail.com koonin@ncbi.nlm.nih.gov f.demichelis@unitn.it horn@tau.ac.il.

Francesca Demichelis (F)

Department of Cellular, Computational and Integrative Biology, University of Trento, 38123 Trento, Italy; erezpersi@gmail.com koonin@ncbi.nlm.nih.gov f.demichelis@unitn.it horn@tau.ac.il.
Division of Hematology and Medical Oncology, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10065.

David Horn (D)

School of Physics and Astronomy, Raymond & Beverly Sackler Faculty of Exact Sciences, Tel Aviv University, 69978 Tel Aviv, Israel; erezpersi@gmail.com koonin@ncbi.nlm.nih.gov f.demichelis@unitn.it horn@tau.ac.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH